RecruitingNCT05974150

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring


Sponsor

Carevive Systems, Inc.

Enrollment

25 participants

Start Date

Jul 19, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study uses a remote symptom monitoring app to track how patients with certain cancers feel during treatment. Researchers want to understand how symptoms change over time and whether digital tools can improve care. **You may be eligible if...** - You are 18 or older - You have been diagnosed with breast cancer, lung cancer, ovarian cancer, multiple myeloma, or acute myeloid leukemia (AML) - You are at any stage of treatment - You can complete online surveys on a phone, tablet, or computer - You understand written English **You may NOT be eligible if...** - You cannot understand written or spoken English - You do not have access to a phone, tablet, or computer to complete surveys - You are currently enrolled in a treatment clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERWeb based survey

online weekly survey


Locations(7)

Yale Cancer Center

New Haven, Connecticut, United States

Northshore University Health System

Evanston, Illinois, United States

Univeristy of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Duke

Durham, North Carolina, United States

Cleveland Clinic Mercy Hospital

Canton, Ohio, United States

University Hospitals Seidman Cancer Center

Cleveland, Ohio, United States

Tri-County Hematology & Oncology Associates, Inc.

Massillon, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05974150


Related Trials